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Abstract The anti-apoptotic protein Bcl-2 functions as a crucial
negative regulator of apoptosis. Bcl-2 has been shown to prevent
the efflux of apoptogenic factors from mitochondria to cytosol,
thus inhibiting cell death. Here, we show the susceptibility of a
spontaneously regressing, rat histiocytic tumor cell line, AK-5, to
the apoptotic effects of diverse stimuli and the ability of Bcl-2
overexpression to block cell death. Bcl-2 overexpression
selectively inhibits apoptosis induced by ceramide and serum
factor from AK-5 tumor regressing animals but not actinomycin
D and curcumin, whereas the pancaspase inhibitor z-Val-Ala-Asp
fluoromethylketone completely blocks apoptosis, irrespective of
the inducer used. The ability of Bcl-2 overexpression to block cell
death does not depend on its ability to prevent cytochrome c
release but correlates with its ability to prevent the dissipation of
mitochondrial transmembrane potential. The results demonstrate
that there are inducer dependent redundant activation pathways
in a single cell, which may either be Bcl-2 dependent or
independent. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The Bcl-2 family of proteins constitutes one of the most
crucial classes of apoptosis-regulatory proteins. These include
both the pro-apoptotic (Bax, Bad, Bak, Bid, Bcl-Xs, Bim, Bik)
and anti-apoptotic (Bcl-2, Bcl-XL, Bclw, Mcl1) proteins [1,2].
These proteins are mostly localized to the outer membranes of
mitochondria, endoplasmic reticulum and nucleus, as a result
of a carboxy-terminal membrane anchor [3]. Members of this
family are capable of dimerization and the ratio of pro- to
anti-apoptotic molecules determines, in part, the susceptibility
of cells to undergo programmed cell death [4]. The proto-
oncogene Bcl-2 was originally isolated from human follicular
lymphomas harboring a t(14;18) chromosomal translocation
[5]. It is found primarily at the outer^inner membrane contact
sites of mitochondria, where permeability transition (PT)
pores are expected to form [6]. Bcl-2 inhibits cell death in
response to diverse stimuli [2] and inhibits both the mitochon-
drial and nuclear manifestations of apoptosis. The precise
mechanism by which Bcl-2 modulates cell death is not clearly
understood but its anti-apoptotic functions are attributed to
the reduction of reactive oxygen species levels [7], e¡ect on the
mitochondrial proton £ux and modulation of mitochondrial
calcium homeostasis [8,9]. Bcl-2 also inhibited the release of
cytochrome c and an apoptogenic protease from the inner
membrane space of mitochondria into the cytosol, thus pre-
venting caspase activation and cell death [10^12]. However
both the mechanisms of cytochrome c redistribution and its
regulation by Bcl-2 remain controversial.
Work in our lab is focussed on deciphering the molecular
mechanisms responsible for the spontaneous regression of
AK-5 tumor, a rat histiocytoma [13]. We have earlier shown
the ability of the serum factor from tumor regressing animals
to induce apoptosis in AK-5 cells in vitro. In the present
study, we show the susceptibility of AK-5 tumor cells to the
apoptotic e¡ects of serum factor from tumor regressing ani-
mals, curcumin (a pigment derived from the rhizome of Cur-
cuma longa), actinomycin D (transcriptional inhibitor) and
ceramide (the pleiotropic lipid second messenger) [14^16]
and the regulation of cell death in these cells by Bcl-2.
2. Materials and methods
2.1. Animals, tumor and cell culture
AK-5 tumor was maintained as ascites in an inbred colony of Wis-
tar rats by injecting 5U106 tumor cells intraperitoneally (i.p.) [13].
Animals which were injected with tumor cells (5U106) subcutaneously
(s.c.) and had rejected the tumor were used as the source for anti-AK-
5 antiserum (serum factor). We have used a single cell clone of AK-5
adapted to grow in vitro, called BC-8 in all the studies, to avoid
ambiguity in results due to tumor heterogeneity [17]. BC-8 cells
were grown in Dulbecco’s modi¢ed Eagle’s medium supplemented
with 10% (v/v) heat-inactivated fetal calf serum in an atmosphere of
95% air and 5% CO2. Cell viability was assessed by trypan blue dye
exclusion assay.
2.2. Induction of apoptosis and £uorescence microscopy
After treatment with the serum factor for appropriate time, cells
were washed with phosphate-bu¡ered saline (PBS), and ¢xed in 80%
methanol. Cells were stained with 1 Wg/ml propidium iodide (PI) re-
agent (Calbiochem), and observed under a £uorescence microscope
(Nikon Optiphot). Apoptotic cells were identi¢ed based on the frag-
mented nuclear morphology.
2.3. Subcellular fractionation and Western blotting
Extraction of mitochondria and cytosol was done according to the
previously published procedure [18]. Brie£y, BC-8 cells (5U106), at
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 5 4 3 - 1
*Corresponding author. Fax: (91)-40-7171195.
E-mail: khar@ccmb.ap.nic.in
Abbreviations: zVAD-fmk, z-Val-Ala-Asp £uoromethylketone; PT,
permeability transition; CCCP, carbonylcyanide m-chlorophenylhy-
drazone; vim, mitochondrial transmembrane potential; DiOC6(3),
3P,3P-dihexyloxacarbocyanine
FEBS 24964 12-6-01
FEBS 24964FEBS Letters 499 (2001) 166^170
the end of the treatment, were washed with ice-cold PBS, and resus-
pended in 50 Wl of bu¡er A (20 mM HEPES^KOH, pH 7.5, 10 mM
KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA,
1 mM dithiothreitol) containing 250 mM sucrose and protease inhib-
itors (1 mM PMSF, 1 Wg/ml each of leupeptin, aprotinin, pepstatin
and chymostatin). The cells were homogenized by giving 40 strokes in
a glass homogenizer using a B type pestle. Unlysed cells and nuclei
were removed by centrifuging the supernatants at 1000Ug at 4‡C for
10 min. The resulting supernatant was subjected to 10 000Ug centri-
fugation at 4‡C for 20 min. The pellet fraction (mitochondria) was
washed with bu¡er A, and solubilized in TNC bu¡er (10 mM Tris^
acetate, pH 8.0, 0.5% NP-40, 5 mM CaCl2). The supernatant was
recentrifuged at 100 000Ug (4‡C, 1 h) to generate cytosol. Protein
concentration was determined by Lowry’s method. 25 Wg of pellet
fractions and 50 Wg of cytosolic fractions were subjected to 12.5%
SDS^PAGE. Separated proteins were transferred to a nitrocellulose
membrane and probed with 1:1000 dilution of a monoclonal antibody
to cytochrome c (Pharmingen, San Diego, CA, USA). Mitochondrial
contamination of cytosolic extracts was determined by probing the
blot with mouse anti-cytochrome c oxidase subunit IV (Molecular
Probes Inc., Eugene, OR, USA). The blots were treated with an ap-
propriate secondary antibody conjugated to alkaline phosphatase
(Boehringer Mannheim) and developed using NBT and BCIP.
2.4. Transfection of BC-8 cells with Bcl-2 gene
BC-8 cells (2U106) were transfected with the linearized pMEP4
vector, with and without full length murine Bcl-2 gene by the electro-
poration method described earlier [19]. The transfected clones were
selected with hygromycin B (400 Wg/ml) for 14 days. Single cell clones
were obtained by limiting dilution procedure. Clones were screened by
Northern hybridizations and immuno£uorescence assay (data not
shown) and the positive clones were expanded and used in these
studies.
2.5. Measurement of mitochondrial transmembrane potential (vim)
Mitochondrial energization was determined as the retention of the
dye 3P,3P-dihexyloxacarbocyanine, DiOC6(3) (Molecular Probes Inc.,
Eugene, OR, USA). BC-8 cells (1U106) at di¡erent time points of
apoptotic induction were washed with PBS, and treated with 50 nM
DiOC6(3) at 37‡C for 30 min. The cells were washed and the quanti-
tation of cells retaining DiOC6(3) was done in a FACStar PLUS
Cyto£uorometer (Becton-Dickinson, San Jose, CA, USA), using the
Cell-Quest software. Carbonylcyanide m-chlorophenylhydrazone
(CCCP; 50 WM) was used as a positive control for maximum vim
disruption.
Mitochondrial membrane potential was also analyzed by confocal
laser scanning microscopy on a Meridian Ultima Scan head attached
to an Olympus IMT-2 inverted microscope after staining cells with
DiOC6(3) and Hoechst (1 Wg/ml).
3. Results
3.1. Induction of apoptosis in AK-5 cells by di¡erent stimuli
AK-5 tumor, a rat histiocytoma, is being maintained as
ascites in an inbred colony of Wistar rats. When injected
i.p., AK-5 tumor is highly malignant and kills all the animals,
but s.c. transplantation results in solid tumors which regress
spontaneously in 80% of the animals. The animals which had
rejected the tumor were immune to further challenges of the
tumor by either route, and the serum from these animals had
a potent apoptosis inducing ability on the AK-5/BC-8 cells in
vitro.
We have seen the susceptibility of BC-8 cells to the apopto-
tic e¡ects of the serum factor (10% v/v) from tumor regressing
animals as well as curcumin (25 WM), the synthetic C8-ceram-
ide (50 Wm) and actinomycin D (1 Wg/ml). BC-8 cells upon
induction of apoptosis with these agents underwent all the
classical features of apoptosis with exquisite synchrony like
chromatin and cytoplasmic condensation, membrane blebbing
and DNA fragmentation. Most of the cells were rendered
apoptotic by 12 h of treatment as seen by PI staining (Table
1).
3.2. Inhibition of apoptosis by Bcl-2 overexpression is inducer
dependent
Apoptosis induced in BC-8 cells by di¡erent apoptotic stim-
uli proceeds with the activation of caspase-3. In order to as-
certain the involvement of caspases during apoptosis, BC-8
cells were pretreated with a broad spectrum, cell permeable
inhibitor of caspases, z-Val-Ala-Asp £uoromethylketone
(zVAD-fmk) (100 Wm), for 30 min, followed by induction
with serum factor, curcumin, actinomycin D and C8-ceram-
ide. zVAD treatment completely inhibited the appearance of
apoptotic morphology and DNA fragmentation as assessed
by PI staining (Fig. 1). Surprisingly Bcl-2 overexpression in-
hibited apoptotic cell death induced by serum factor and cer-
amide and the cells proliferated normally whereas Bcl-2 over-
expression had no e¡ect in cells treated with actinomycin D
and curcumin.
3.3. The ability of Bcl-2 overexpression to block cell death does
not correlate with its ability to prevent cytochrome c
release
Apoptosis in BC-8 cells induced with all the four apoptotic
agents proceeds with the translocation of cytochrome c from
mitochondria to cytosol. Western analysis was done to detect
Table 1
Quantitative determination of apoptosis in BC-8 cellsa
Group Apoptotic cells (%)
1. Control BC-8 cells 5.3
2. BC-8 cells+serum factor 69.0
3. BC-8 cells+curcumin (25 WM) 80.3
4. BC-8 cells+actinomycin D (1 Wg/ml) 75.9
5. BC-8 cells+ceramide (50 WM) 65.5
aBC-8 cells were treated with various inducers for 12 h, ¢xed and
stained with PI. The values are representative of three independent
experiments.
Fig. 1. Di¡erential pattern of inhibition of apoptosis in BC-8 cells
overexpressing Bcl-2 or pretreated with zVAD-fmk. Bcl-2 overex-
pressing cells and BC-8 cells pretreated with zVAD-fmk (100 WM)
for 1 h were induced for 12 h with serum factor (2), 25 WM curcu-
min (3), 1 Wg/ml actinomycin D (4), 50 WM C8-ceramide (5). (1) rep-
resents untreated cells. Cells were ¢xed and stained with PI. Data
represent mean þ S.E.M. of three independent experiments.
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the levels of cytochrome c in both soluble cytosolic and the
mitochondria-enriched, heavy membrane fractions (the pellet),
obtained after treatment of cells with di¡erent inducers of
apoptosis. The results showed a signi¢cant e¥ux of this pro-
tein from mitochondria to cytosol, very early during apopto-
sis, which increased with time, reaching a peak at 10 h with a
concomitant decrease in the immunoreactivity of the pellet
fraction (Fig. 2A). The absence of cytochrome c oxidase (sub-
unit IV) in the supernatant fraction rules out the possibility of
mitochondrial contamination in cytosolic extract preparations
(Fig. 2A).
With a view to investigate whether the inhibitory potential
of Bcl-2 overexpression re£ects its ability to prevent cyto-
chrome c release, Western analysis of both the cytosolic and
the pellet fraction of Bcl-2 overexpressing cells induced with
all the four apoptotic agents was done. As shown in Fig. 2B,
there was no correlation between the inhibition of cell death
by Bcl-2 and cytochrome c release. Cytochrome c e¥ux was
seen irrespective of the ability or inability of Bcl-2 to block
cell death.
3.4. The inducer dependent ability of Bcl-2 overexpression to
inhibit apoptosis correlates with its ability to prevent vim
Loss of vim is a late event during apoptosis in BC-8 cells,
which paralleled DNA fragmentation. We have monitored the
mitochondrial membrane potential of BC-8 cells by £ow cy-
tometry, using the mitochondrial potential-sensitive dye DiO-
C6(3). Treatment of cells with all the four apoptotic inducers
led to the dissipation of mitochondrial membrane potential by
8 h of treatment (Fig. 3A). Cells treated with 50 WM CCCP, a
protonophore, resulted in complete collapse of vim, suggest-
ing that the uptake of DiOC6(3) depends on the H gradient
in mitochondria.
In an e¡ort to investigate whether inhibition of cell death
by Bcl-2 correlates with its ability to prevent the dissipation of
vim, Bcl-2 overexpressing clone was treated with di¡erent
apoptotic inducers for 8 h, stained with DiOC6(3) and the
vim was quantitated by £ow cytometry. Fig. 3B shows that
overexpression of Bcl-2 prevented the loss in vim in cells
treated with the serum factor and ceramide (panels b, e),
whereas in Bcl-2 cells treated with curcumin and actinomycin
D, there is dissipation of vim, resulting in cell death (panels c,
d). The uptake of the potential-sensitive dye was also exam-
ined by dual staining of cells with DiOC6(3) and Hoechst
followed by confocal analysis, which showed a correlation
between perturbation in vim and cell death (Fig. 4A). Fig.
Fig. 2. Bcl-2 overexpression does not prevent cytochrome c e¥ux in
BC-8 cells. (A) Western blot analysis showing the time bound re-
lease of cytochrome c into the cytosol. Apoptosis was induced in
BC-8 cells by the serum factor (a), 25 WM curcumin (b), 1 Wg/ml ac-
tinomycin D (c) and 50 WM C8-ceramide (d). (B) Cytochrome c
translocation is also shown by Western analysis of mitochondrial
and cytosolic fractions of Bcl-2 overexpressing cells induced with
the serum factor (a), 25 WM curcumin (b), 1 Wg/ml actinomycin D
(c) and 50 WM C8-ceramide (d). COXIV staining in (A) and (B)
serves as loading control and also rules out the possibility of mito-
chondrial contamination in the cytosol.
Fig. 3. Quantitation of vim by DiOC6(3) staining by £ow cytomet-
ry. A: (a) represents untreated BC-8 cells; (c), (d), (e) and (f) repre-
sent BC-8 cells treated with the serum factor, 25 WM curcumin,
1 Wg/ml actinomycin D and 50 WM ceramide respectively. As a posi-
tive control for the reduction in vim, cells were treated with CCCP
(50 WM), a mitochondrial uncoupling agent (b). B: (a) represents
untreated Bcl-2-transfected cells, (b), (c), (d) and (e) represent Bcl-2
cells treated with the serum factor, 25 WM curcumin, 1 Wg/ml acti-
nomycin D and 50 WM ceramide respectively.
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4B shows the extent of cell death in both untransfected and
Bcl-2-transfected cells at 8 h post-induction, the time at which
the state of mitochondrial integrity was determined.
4. Discussion
Mitochondria have been shown to be the control point in
the mainstream of apoptotic cascade in many cell types [20] as
well as in cell-free systems [21]. Apoptosis in the majority of
cells studied proceeds with the translocation of apoptogenic
factors such as cytochrome c [10,11,22] and apoptosis induc-
ing factor [12] from mitochondria to the cytosol. In the cyto-
sol, cytochrome c forms a complex with Apaf-1 and caspase-9,
leading to the activation of caspase-3 [23]. The mechanism by
which cytochrome c is released into the cytosol is controver-
sial but seems to be regulated in part by the Bcl-2 family of
proteins [10,11]. The relative expression levels of the Bcl-2
proteins regulate cell death by controlling mitochondrial ho-
meostasis. The anti-apoptotic protein Bcl-2 prevents pro-
grammed cell death in response to a wide variety of stimuli,
but the biochemical mechanism governing its cytoprotective
e¡ect is not clearly established. The ectopic expression of the
pro-apoptotic protein Bax was shown to trigger cytochrome c
release from mitochondria, in the absence of any death stim-
ulus [24]. The death protective e¡ect of Bcl-2 was linked to its
ability to prevent the e¥ux of cytochrome c and caspase acti-
vation [10,11]. Bcl-2 has also been shown to inhibit the ion-
conducting channel forming activity of Bax in vitro [25].
To investigate the role of Bcl-2 in regulating mitochondrial
function, we explored the alterations in mitochondrial physi-
ology that follow diverse apoptotic stimuli and the ability of
Bcl-2 to counteract these changes in a single cell type.
Curcumin is the active component of turmeric used com-
monly as a spice and has been shown to exhibit anti-muta-
genic and anti-carcinogenic activities in addition to anti-in-
£ammatory activities [26,27]. Curcumin was highly potent in
inducing all the classical manifestations of apoptotic cell death
in AK-5 cells.
Ceramide, a product of sphingomyelin hydrolysis, is con-
sidered as a lipid second messenger with pleiotropic e¡ects
[16]. Increased levels of ceramide have been correlated with
terminal di¡erentiation and apoptotic processes [28]. Actino-
mycin D, an inhibitor of macromolecular synthesis, induces
apoptosis in AK-5 cells at a concentration which inhibits
RNA synthesis, suggesting that cell death may result due to
the inhibition of synthesis of some regulatory proteins which
are required for maintaining cell survival and which prevent
triggering of cell death in AK-5 cells.
Apoptosis induced in AK-5 cells by all the four stimuli
involved the activation of caspases and the redistribution of
cytochrome c to the cytosol, very early during apoptosis. As
opposed to the earlier studies, which demonstrated a disrup-
tion in vim to be an early event, resulting in apoptosis [29],
our studies indicate that the disruption of vim was a late
event which paralleled DNA fragmentation representing the
point of no return in apoptosis, and the e¥ux of cytochrome c
is not a consequence of the disruption in vim.
Bcl-2 had a di¡erential e¡ect in the regulation of apoptosis
in AK-5 cells induced with diverse stimuli. Overexpression of
Bcl-2 completely blocked apoptosis induced by the serum fac-
tor and ceramide, and the cells proliferated normally, whereas
it had no e¡ect on apoptosis induced by actinomycin D and
curcumin. The cytoprotective ability of Bcl-2 was not a con-
sequence of the inhibition of the cytochrome c release as re-
ported earlier [10,11], as cells induced by all the inducers
underwent cytochrome c redistribution to the cytosol. The
depletion of cytochrome c, a protein obligatory for cell sur-
vival, had no e¡ect on the viability of cells, treated with serum
factor and ceramide. Recent studies demonstrated that the
translocation of cytochrome c is a reversible event with the
depleted cells acquiring cytochrome c by de novo protein syn-
thesis [30]. Consistent with our ¢ndings, it was shown that
microinjection of cytochrome c in cells resulted in apoptosis
that could not be inhibited by Bcl-XL expression [31].
Mitochondrial transmembrane depolarization, presumed to
be mediated by PT, was shown to irreversibly commit cells to
undergo apoptosis, even when the apoptosis inducing stimulus
is removed [29]. With the evidence that Bcl-2 can block mi-
Fig. 4. Determination of vim disruption by confocal microscopy.
A: BC-8 cells upon induction of apoptosis for 8 h by serum factor
(b) (shown as a representative) were stained with 50 nM DiOC6 and
counter-stained with Hoechst (1 Wg/ml), followed by confocal mi-
croscopy. (d) represent Bcl-2 overexpressing cells induced with se-
rum factor. (a) and (c) represent untreated BC-8 cells and BC-8 cells
treated with 50 Wm CCCP. Images were obtained by confocal analy-
sis of a 0.2 Wm optical section. Scale bar represents 10 Wm. B:
Quantitation of apoptosis in BC-8 and Bcl-2-transfected cells by PI
staining and £uorescence microscopy after cells were induced for 8 h
by serum factor (2), 25 WM curcumin (3), 1 Wg/ml actinomycin D
(4) and 50 WM C8-ceramide (5). (1) represents untreated cells. Data
represent mean þ S.E.M. of three independent experiments.
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tochondrial PT induced by treatment of isolated mitochondria
with a variety of agents [32], we investigated whether the
di¡erential inhibitory potential of Bcl-2 correlates with its
ability to regulate vim disruption.
Bcl-2 overexpression prevented vim disruption in cells
treated with the serum factor and ceramide, but could not
rescue vim in cells induced by curcumin and actinomycin
D. This may re£ect di¡erent systemic levels of damage of
mitochondrial membrane integrity and subsequent disruption
of mitochondrial function, which may or may not be over-
come by Bcl-2 overexpression.
It is also demonstrated earlier that apoptosis in some types
of cells triggered by Fas (CD 95) and certain members of the
tumor necrosis factor family of death receptors runs via a Bcl-
2 independent pathway, circumventing the participation of
mitochondria [33,34]. The ability of Bcl-2 to di¡erentially pro-
tect AK-5 cells against apoptosis can be explained by postu-
lating that there are additional parallel pathways that are
related, but independent of Bcl-2, and Bcl-2 prevents apopto-
sis by virtue of its PT-inhibitory potential.
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